UPDATE: Citadel Securities Initiates Coverage on Human Genome Sciences

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Citadel Securities has published a report on Human Genome Sciences (NASDAQ: HGSI) initiating coverage on the biotech company.In the report, Citadel wrote, "We believe investors and the Street are singularly focused on Benlysta, resulting inthe opportunity for potential upside on the “hidden value” of the company's pipeline, which includes two GSK Phase III assets to which HGSI has substantial financial rights."Citadel rated Human Genome Sciences an ADD with a price target of $25.00. Human Genome Sciences closed Friday at $15.81.

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!